Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-11-24

Clinical Trial Update: Effect of Targeting Left Ventricular Lead Position on the Rate of Response to Cardiac Resynchronization Therapy. [Phase 2, Phase 3]

View source ↗

Summary

This completed Phase 2/3 clinical trial evaluated whether optimizing the left ventricular lead position improves the response rate to cardiac resynchronization …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University of Calgary | Conditions: Heart Failure, Congestive, Cardiac Pacing, Artificial | Phase 2, Phase 3 | Status: COMPLETED